RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5.

Gao, Xing; Lu, Cheng; Liu, Ziyu; Lin, Yan; Huang, Julu; Lu, Lu; Li, Shuanghang; Huang, Xi; Tang, Minchao; Huang, Shilin; He, Ziqin; She, Xiaomin; Liang, Rong; Ye, Jiazhou

Gao, Xing; Lu, Cheng; Liu, Ziyu; Lin, Yan; Huang, Julu; Lu, Lu; Li, Shuanghang; Huang, Xi; Tang, Minchao; Huang, Shilin; He, Ziqin; She, Xiaomin; Liang, Rong; Ye, Jiazhou.

Afiliação

Gao X; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Lu C; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Liu Z; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Lin Y; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Huang J; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Lu L; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Li S; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Huang X; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Tang M; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Huang S; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
He Z; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
She X; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Liang R; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Ye J; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.